ArticleNeurology(R) neuroimmunology & neuroinflammation2020

Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis.

Jamie Brannigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.